#Biotech M&A deals during last bubble didn't work out too well... $MRK -> Cubist $9.5B $ALXN -> Synageva $8.4B $CELG -> Receptos $7.2B $ABBV -> Stemcentrx $5.8B $MRK -> Idenix $3.8B $AZN -> ZS Pharma $2.7B https://twitter.com/andybiotech/status/976864363909926920?s=21